Cardio pharmacology (II): Rate And Rhythm Control Flashcards

1
Q

Digoxin indication

A

Atrial fibrillation or flutter.
Heart failure
Emergency loading dose for atrial fibrillation or flutter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Digoxin Therapeutic Range

A

0.7 to 2 nanogram/mL (wide inter-individual variations).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you start digoxin (dose)

A

Loading dose of 250 micrograms to 750 micrograms for 7 days followed by maintenance dose 125 micrograms-250 micrograms adjusted according to renal function and heart rate response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is max maintenance dose of digoxin.

(a) 250 micrograms
(b) 125 micrograms
(c) 300 micrograms
(d) 150 micrograms

A

(a) 250 micrograms daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When would you suspect DigToxicity.
(a) 0.5 nanogram/mL
(b) 3.0 nanograms/mL
(c) 3.0 nanograms/L
(d)1.5 nanogram/mL in presence of hypokalemia
(e) 0.8 nanograms.
(f) 1.8 nanograms/L nanograms

A

(b) 3.0 nanograms/mL + (d) 1.5 nanogram/mL in presence of hypokalemia because dig toxicity is more pronounced in hypokalemia due to less competition to bind to sodium potassium pump.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the symptoms of DigToxicity.

A

Confusion, nausea, anorexia, visual colour disturbances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the antidote for DigToxicity

A

DigiFab antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Monitoring for Digoxin
(a) Routine monitoring
(b) Monitoring when patient presents with confusion and visual colour disturbances
(c) Monitoring when patient is on amiodarone or diltiazem
(d) Monitoring when patient comes in for regular blood pressure and heat rate monitoring.

A

(b) and (c)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is being monitored for digoxin and why.

A

Serum electrolytes (K+, Mg2+ and Ca2+) as electrolyte imbalances (hypokalaemia, hypo magnesia, and hypercalcaemia) can potentiate toxicity, renal function and heart rate ( HR greater than 60 bpm).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What HR do you want patients to be at whilst on digoxin.

A

> 60 bpm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanism of Digoxin and its effects on cardiac tissue.

A

Digoxin inhibits sodium-potassium ATPase pump increasing the contractility of the heart by increase sodium and in turn calcium forming more cross-bridges to allow for powerful contractions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanism of Digoxin nodal cells.

A

Reduces AV node conduction via the vagus nerve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Does digoxin affect preload/afterload/stroke volume and is it an increase or decrease or no effect.

A

Digoxin increases stroke volume.
Digoxin have no effect on preload.
Digoxin has no effect on after load.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is digoxin a negative chronotrope or inotrope.

A

Chronotrope.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is digoxin a positive chronotrope or inotrope.

A

Inotrope.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Digoxin adverse effects

A

Arrhythmias, possible AV block.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Digoxin: Caution and Contraindication

A

Heart Block.
Renal Failure.
Electrolyte imbalance
HF: patient on selective calcium channel blocker-> cardio-suppressant effects.

18
Q

Pharmacokinetics of digoxin: a. Half-life? b. Excreted by which organ. c. When is steady state concentration achieved?

A

a. 30-40 h.
b. Kidney
c. 5-7 days

19
Q

Pharmacokinetics Digoxin: a. Metabolism.

A

a. CYP3A4 enzymes

20
Q

How is digoxin renally cleared and the clinical significance with diuretics.

A

Digoxin is excreted by the nephrons through tubular secretion and drugs that inhibit tubular secretion such as spironolactone and amiodarone can cause a build up of digoxin. Also renal impairment slows down elimination leading digoxin toxicity.

21
Q

What drugs can impair renal function and effect digoxin excretion.

A

ACE-inhibitor and NSAIDs.

22
Q

What drug when used concomitantly with digoxin will increase the risk of pro-arrhythmia.

A

Tricyclic antidepressant: block noradrenaline and adrenaline uptake increasing risk of SNS activation.

23
Q

Which serotonergic receptor is implicated in pro-arrthymia.

A

Serotonin acts solely via 5-HT4-receptors to control human cardiac contractile … It may be assumed that 5-HT can exert a proarrhythmic effect

24
Q

What drug when used concomitantly with digoxin will increase digoxin levels.

A

Diuretics
Proton pump inhibitor

25
Q

What herbal remedy when used concomitantly with digoxin will reduce digoxin level.

A

St. John’s Wort.

26
Q

Is amiodarone a positive or negative chronotrope.

A

Negative

27
Q

Is amiodarone a positive or negative inotrope

A

(Very little effect) Negative.

28
Q

Amiodarone effect on after load/Preload/cardiac conduction/cardiac output- increase decrease or no effect.

A

Amiodarone decreases peripheral resistance (after load) due to vasodilation of vessels by beta and alpha antagonism.
Preload: no effect
Cardiac output: marginal increase.
Cardiac conduction: decreased.

29
Q

Amiodarone mechanism of action.

A

Blockade of sodium, calcium and potassium channels and antagonism of the alpha and beta-adrenergic receptors.

30
Q

Amiodarone pharmacodynamic effects.

A

Reduces spontaneous depolarisation (automaticity).
Slows conduction velocity and increases resistance to depolarisation (refractoriness).
Prevents self-perpetuating re-entry circuit, including AV node, thus restoring sinus rhythm.

31
Q

Adverse effect of Amiodarone. (Think 79-year-old woman case study)

A

Nausea, vomiting and taste disturbance associated with loading dose.
Pulmonary toxicity (pneumonitis and fibrosis) which can occur during the therapy (79 yr old woman).
Thyroid dysfunction: hypo/hyperthyroidism due to its resemblance to iodine.
Cardiac toxicity: bradycardia and conduction disturbances associated with increasing dose.
Visual disturbance: corneal micro deposits.
Photosensitivity reaction: common and persist several months after stopping amiodarone treatment. Blue discolouration.

32
Q

What is the baseline test that need to be carried out before initiating amiodarone.

A

Liver function test, urea & electrolytes, thyroid function test, chest X-ray and electrocardiography.

33
Q

What is the half life of amiodarone.
a. 60 days
b. 12 days
c. 80 days
d. 50 days

A

(d) 50 days.

34
Q

Caution and contraindication Amiodarone

A

Heart block
Liver failure.
Elderly.
Hypotension.

35
Q

What enzymes does Amiodarone inhibit or induce.

A

Inhibitor of CYP3A4, CY2C9.

36
Q

Does Amiodarone increase or decrease the concentration of Simvastatin.

A

Increase. CYP3A4 inhibitor.

37
Q

Which drug-drug interaction causes rhabdomyolysis.
a. Amiodarone +simvastatin.
b. Amiodarone + warfarin.
c. Warfarin +Simvastatin.
d. Simvastatin + Carbamazepine.
e. Grapefruit +simvastatin.

A

(a) amiodarone and simvastatin.

38
Q

Mechanism of flecainide

A

Sodium channel blocker.

39
Q

CYP enzyme flecainide inhibits or induce

A

CYP2D6 inhibitor

40
Q

Which interaction increases the concentration of dexamethasone
a. dexamethasone + warfarin
b. dexamethasone + carbamazepine
c. dexamethasone + amiodarone
d. Dexamethasone + flecainide

A

(d) Flecainide